Embryoman

Embryoman Reporting on the latest IVF research, in simple terms, on Remembryo.

***๐…๐จ๐ซ ๐ฅ๐ข๐ง๐ค๐ฌ ๐ญ๐จ ๐ฆ๐ฒ ๐œ๐จ๐ง๐ญ๐ž๐ง๐ญ, ๐ฏ๐ข๐ฌ๐ข๐ญ ๐ฆ๐ฒ ๐‹๐ˆ๐๐Š ๐ˆ๐ ๐๐ˆ๐Ž: https://lnk.bio/embryoman***

(Sponsored by the European Fertility Society)Tell us about your infertility treatment experience by filling out a survey...
15/11/2024

(Sponsored by the European Fertility Society)

Tell us about your infertility treatment experience by filling out a survey. By participating, you'll have a chance to win a ยฃ30 voucher!

We need your help to make a difference in fertility care!

Survey link is in the comments.

A recent study found that working past 4 pm, specific procedures, and variability among embryologists all contribute to ...
14/11/2024

A recent study found that working past 4 pm, specific procedures, and variability among embryologists all contribute to errors in the IVF lab.

Avoiding errors in the IVF lab is important to ensure the right s***m and eggs are combined, the right embryo is thawed, and the right embryo is transferred!

Electronic witnessing systems can be used to help reduce errors by using radio frequency ID (RFID) or barcodes placed on patient ID cards and cell culture vessels. The system alarms when mismatches are detected (all mismatches were prevented by the system).

A recent study reported on RFID mismatches in their lab between 2016 and 2023.

They found that mismatches occurred more frequently after 4 pm, for certain procedures like the embryo transfer, and for certain embryologists. The two embryologists with the highest mismatch rate had over 20 years of experience! This may be due to increased multitasking by more experienced embryologists.

Besides this study, other studies have highlighted the challenges embryologists face in the lab, with reports of high stress levels and vision problems due to excessive microscope use, which could contribute to errors. One study found that embryologists have the highest level of burnout among all IVF staff.

This has led to certain organizations, like the ASRM, to provide guidance on the number of embryologists needed for a lab based on the number of cycles they perform.

Effective staffing and making efforts to ensure embryologists arenโ€™t fatigued, along with a good workflow and witnessing system, can help reduce errors in the IVF lab.

Check out all the details on Remembryo, link is in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter!

๐‡๐š๐ฏ๐ž ๐ฒ๐จ๐ฎ ๐ž๐ฑ๐ฉ๐ž๐ซ๐ข๐ž๐ง๐œ๐ž๐ ๐š๐ง๐ฒ ๐ˆ๐•๐… ๐ฅ๐š๐› ๐ž๐ซ๐ซ๐จ๐ซ๐ฌ?

Rescue IVM (in vitro maturation) can increase the number of mature eggs you get after a retrieval!After a retrieval, the...
13/11/2024

Rescue IVM (in vitro maturation) can increase the number of mature eggs you get after a retrieval!

After a retrieval, there's a pretty good chance that not all of the collected eggs will be mature and able to be inseminated.

When eggs mature, they go through several stages: GV --> M1 --> M2. Only an M2 egg is mature.

So what happens when you get a GV or M1 egg that's immature? Unfortunately, since these eggs canโ€™t be inseminated, theyโ€™re usually discarded.

However, it's possible to let the immature eggs sit for a few hours or overnight and let them mature in the lab. This is known as rescue IVM and it can increase the number of mature eggs a patient has.

Studies have shown that these eggs have a reduced chance of fertilization and are less likely to become blastocysts, but this technique may be worth it for patients who don't have many mature eggs.

Check out a couple of studies on Remembryo, link is in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter!

๐‡๐š๐ฏ๐ž ๐ฒ๐จ๐ฎ ๐ญ๐ซ๐ข๐ž๐ ๐ซ๐ž๐ฌ๐œ๐ฎ๐ž ๐ˆ๐•๐Œ? ๐ƒ๐ข๐ ๐ฒ๐จ๐ฎ ๐ ๐ž๐ญ ๐ฆ๐จ๐ซ๐ž ๐ฆ๐š๐ญ๐ฎ๐ซ๐ž ๐ž๐ ๐ ๐ฌ?

12/11/2024

Researchers have created the most detailed 3D map of an embryo yet.

The 3D map shows the early structures of major organs in the mouse embryo at 11.5 days past conception (equivalent to 38 days past conception in humans).

To build this map, researchers generated about 90 slices of an embryo and analyzed the gene expression data (RNA transcriptome) for each of the ~8 million cells in these slices.
Each dot shown in the video corresponds to a single cell.

Using this data, the researchers built a model called Spateo, which can one day be used to create 3D embryo maps for any species, including humans.

The researchers believe that these maps could help identify causes of congenital diseases.

Check out more details on Nature, link is in the comments. Want to stay up to date on new IVF research and news? Follow me and send me a DM with your email and I'll sign you up to my weekly newsletter!

Image and video source: Qiu et al. 2024. Spatiotemporal modeling of molecular holograms. Cell. CC-BY-4.0.

Time for the weekly IVF research brief! Here, I take a brief look at 3 of the top new IVF studies from last week that I ...
11/11/2024

Time for the weekly IVF research brief!

Here, I take a brief look at 3 of the top new IVF studies from last week that I think are most helpful for patients.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. This study examined over 8,200 oocyte donor candidates and found that 65 carried chromosomal abnormalities (0.79%), with reciprocal translocations 5 times higher in donors without children. This research suggests that karyotyping could help detect genetic risks in donors that could be missed using questionnaires.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. This meta-analysis combined the results of 9 studies and found that higher BMI negatively impacts assisted reproductive technology (ART) outcomes in women without other medical conditions, leading to lower pregnancy rates, longer stimulation times and fewer eggs retrieved.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ‘. This randomized controlled trial (high quality study) found that intrauterine PRP in patients with recurrent implantation failure (RIF) improved clinical pregnancy and live birth rates, but also increased pregnancy complications.

Iโ€™m short on time and canโ€™t review all these studies, so let me know which one you'd like to learn more about in detail and I can feature it next week on my IVF research news website, Remembryo. Sign up to my newsletter to make sure you donโ€™t miss it! (send me a DM with your email to be added).

Check out more research briefs and links to all the studies on Remembryo, link is in the comments. Want to stay up to date on new IVF research? Send me a DM with your email and I'll sign you up to my weekly newsletter.

๐–๐ก๐ข๐œ๐ก ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ฐ๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐ฅ๐ข๐ค๐ž ๐ญ๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ?

A new study compared cumulative live birth rates for patients aged 40 to 48, finding that increasing age led to decreasi...
07/11/2024

A new study compared cumulative live birth rates for patients aged 40 to 48, finding that increasing age led to decreasing chances of birth.

In this study, women had up to 10 embryo transfers over a period of two years (with about 4 retrievals per patient). The overall (cumulative) live birth rate was measured.

After 10 transfers, 40-year olds had a cumulative live birth rate of over 55%. In other words, the overall chance of live birth after 10 transfers was 55% in 40-year olds.

This peaked at around 8 or so transfers, meaning that additional transfers after #8 didn't really increase the chances of a live birth.

As women got older, the birth rates decreased.

They also looked at egg retrieval outcomes for patients aged 40-48, with a steady drop in the number of eggs retrieved as age increased.

Check out all the details on Remembryo, link is in my bio, and if you want to stay up to date with the latest IVF research send me a DM with your email!

๐˜›๐˜ฐ ๐˜ท๐˜ช๐˜ด๐˜ช๐˜ต ๐˜ฎ๐˜บ ๐˜ฃ๐˜ช๐˜ฐ, ๐˜ต๐˜ข๐˜ฑ ๐˜ฐ๐˜ฏ ๐˜ฎ๐˜บ ๐˜Œ๐˜ฎ๐˜ฃ๐˜ณ๐˜บ๐˜ฐ๐˜ฎ๐˜ข๐˜ฏ ๐˜ฑ๐˜ณ๐˜ฐ๐˜ง๐˜ช๐˜ญ๐˜ฆ ๐˜ฑ๐˜ช๐˜ค๐˜ต๐˜ถ๐˜ณ๐˜ฆ ๐˜ช๐˜ฏ ๐˜ต๐˜ฉ๐˜ช๐˜ด ๐˜ฑ๐˜ฐ๐˜ด๐˜ต ๐˜ต๐˜ฐ ๐˜จ๐˜ฐ ๐˜ต๐˜ฐ ๐˜ฎ๐˜บ ๐˜๐˜ข๐˜ค๐˜ฆ๐˜ฃ๐˜ฐ๐˜ฐ๐˜ฌ ๐˜ฑ๐˜ข๐˜จ๐˜ฆ. ๐˜–๐˜ฏ๐˜ค๐˜ฆ ๐˜ฐ๐˜ฏ ๐˜ฎ๐˜บ ๐˜ฑ๐˜ข๐˜จ๐˜ฆ, ๐˜บ๐˜ฐ๐˜ถโ€™๐˜ญ๐˜ญ ๐˜ด๐˜ฆ๐˜ฆ ๐˜ฎ๐˜บ ๐˜“๐˜๐˜•๐˜’ ๐˜๐˜• ๐˜‰๐˜๐˜– ๐˜ซ๐˜ถ๐˜ด๐˜ต ๐˜ถ๐˜ฏ๐˜ฅ๐˜ฆ๐˜ณ ๐˜ฎ๐˜บ ๐˜ฑ๐˜ณ๐˜ฐ๐˜ง๐˜ช๐˜ญ๐˜ฆ ๐˜ฑ๐˜ช๐˜ค๐˜ต๐˜ถ๐˜ณ๐˜ฆ. ๐˜ ๐˜ฐ๐˜ถ ๐˜ค๐˜ข๐˜ฏ ๐˜ข๐˜ญ๐˜ด๐˜ฐ ๐˜ด๐˜ฆ๐˜ฏ๐˜ฅ ๐˜ฎ๐˜ฆ ๐˜ข ๐˜‹๐˜”.

Time for the weekly IVF research brief! Here, I take a brief look at 3 of the top new IVF studies from last week that I ...
04/11/2024

Time for the weekly IVF research brief!

Here, I take a brief look at 3 of the top new IVF studies from last week that I think are most helpful for patients.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. The PRESTO study tracked couples trying to conceive and found that drinking alcohol before conception, by either partner, did not increase the risk of miscarriage. This result held true for different types of alcohol and across various demographic groups.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. This study examined risk factors for mismatches/errors in an IVF lab using an electronic witnessing system, analyzing over 73,000 witnessing points from 11,210 treatment cycles. Mismatches were most common during the embryo transfer process and specific times of day, with critical mismatches occurring most frequently after 4pm during oocyte denudation.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ‘. This study utilized the FDA adverse event reporting system (FAERS) to analyze the impact of paternal drug exposure on fertility, pregnancy outcomes, and offspring health. It revealed significant safety signals, particularly diazepamโ€™s link to smaller babies, indicating a strong influence of paternal medications on reproductive health, with drugs for rheumatoid arthritis, cancer, and infections being the most commonly reported.

Iโ€™m short on time and canโ€™t review all these studies, so let me know which one you'd like to learn more about in detail and I can feature it next week on my IVF research news website, Remembryo. Sign up to my newsletter to make sure you donโ€™t miss it! (send me a DM with your email to be added).

Check out more research briefs and links to all the studies on Remembryo, link is in my bio. ๐˜›๐˜ฐ ๐˜ท๐˜ช๐˜ด๐˜ช๐˜ต ๐˜ฎ๐˜บ ๐˜ฃ๐˜ช๐˜ฐ, ๐˜ต๐˜ข๐˜ฑ ๐˜ฐ๐˜ฏ ๐˜ฎ๐˜บ ๐˜Œ๐˜ฎ๐˜ฃ๐˜ณ๐˜บ๐˜ฐ๐˜ฎ๐˜ข๐˜ฏ ๐˜ฑ๐˜ณ๐˜ฐ๐˜ง๐˜ช๐˜ญ๐˜ฆ ๐˜ฑ๐˜ช๐˜ค๐˜ต๐˜ถ๐˜ณ๐˜ฆ ๐˜ช๐˜ฏ ๐˜ต๐˜ฉ๐˜ช๐˜ด ๐˜ฑ๐˜ฐ๐˜ด๐˜ต ๐˜ต๐˜ฐ ๐˜จ๐˜ฐ ๐˜ต๐˜ฐ ๐˜ฎ๐˜บ ๐˜๐˜ข๐˜ค๐˜ฆ๐˜ฃ๐˜ฐ๐˜ฐ๐˜ฌ ๐˜ฑ๐˜ข๐˜จ๐˜ฆ. ๐˜–๐˜ฏ๐˜ค๐˜ฆ ๐˜ฐ๐˜ฏ ๐˜ฎ๐˜บ ๐˜ฑ๐˜ข๐˜จ๐˜ฆ, ๐˜บ๐˜ฐ๐˜ถโ€™๐˜ญ๐˜ญ ๐˜ด๐˜ฆ๐˜ฆ ๐˜ฎ๐˜บ ๐˜“๐˜๐˜•๐˜’ ๐˜๐˜• ๐˜‰๐˜๐˜– ๐˜ซ๐˜ถ๐˜ด๐˜ต ๐˜ถ๐˜ฏ๐˜ฅ๐˜ฆ๐˜ณ ๐˜ฎ๐˜บ ๐˜ฑ๐˜ณ๐˜ฐ๐˜ง๐˜ช๐˜ญ๐˜ฆ ๐˜ฑ๐˜ช๐˜ค๐˜ต๐˜ถ๐˜ณ๐˜ฆ. ๐˜ ๐˜ฐ๐˜ถ ๐˜ค๐˜ข๐˜ฏ ๐˜ข๐˜ญ๐˜ด๐˜ฐ ๐˜ด๐˜ฆ๐˜ฏ๐˜ฅ ๐˜ฎ๐˜ฆ ๐˜ข ๐˜‹๐˜”.

๐–๐ก๐ข๐œ๐ก ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ฐ๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐ฅ๐ข๐ค๐ž ๐ญ๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ?

Time for the weekly IVF research brief! Here, I take a brief look at 3 of the top new IVF studies from last week that I ...
28/10/2024

Time for the weekly IVF research brief!

Here, I take a brief look at 3 of the top new IVF studies from last week that I think are most helpful for patients.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. This meta-analysis combined the results of 16 studies that investigated the impact of embryo storage on reproductive outcomes. They found that storage beyond 12 months was associated with a lower chance of live birth but no differences in rates of preterm delivery or congenital malformations. They noted that embryo quality and improper embryo handling, rather than storage time, may have played a role but they couldn't evaluate this.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. This study evaluated the effectiveness and cost-effectiveness of frozenโ€“thawed embryo transfers without PGT-A in women aged 40 and older. They found lower cumulative live birth rates, and increased costs between ages 40 and 46. The study took place in Japan (so the prices included may not reflect the prices in the US or elsewhere).

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ‘. This study investigated the recurrence of chronic endometritis after antibiotic recovery and fertility treatment, finding that CE came back in about 30% of patients. They found that women who had a hysteroscopy had decreased recurrence, while those with a history of pregnancy loss had increased recurrence.

Iโ€™m short on time and canโ€™t review all these studies, so let me know which one you'd like to learn more about in detail and I can feature it next week on my IVF research news website, Remembryo. Sign up to my newsletter to make sure you donโ€™t miss it! (send me a DM with your email to be added).

More research briefs for the month and links to the studies are on Remembryo, link is in the comment.

๐–๐ก๐ข๐œ๐ก ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ฐ๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐ฅ๐ข๐ค๐ž ๐ญ๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ?

25/10/2024

Researchers have used high-resolution microscopy to observe ovulation in mice, revealing it occurs in three distinct phases.

Each month, a single follicle from one of the ovaries makes it to ovulation, releasing an egg into the fallopian tube where it can be fertilized by s***m to create an embryo that can implant in the uterus.

Researchers, in a recent Nature Cell Biology study, isolated mouse ovarian follicles to capture the ovulation process in high resolution.
They noted three distinct phases of ovulation:

1) Follicle expansion, where fluid flows into the follicle, causing it to grow.

2) Contraction, where smooth muscle cells in the outer follicle layer contract to squeeze the follicle.

3) Follicle rupture, where contractions push follicular fluid containing the egg out from the follicle, completing ovulation. In the video, you can see the egg emerge.

Check out more details from the Max Planck Institute, link is in the comments. Want to stay up to date on new IVF research and news? Follow Embryoman and send me a DM with your email and I'll sign you up to my weekly newsletter!

Source: Thomas, C., Marx, T.L., Penir, S.M. et al. Ex vivo imaging reveals the spatiotemporal control of ovulation. Nat Cell Biol (2024).

Researchers report healthy live births after segmental aneuploid transfers, finding that they have similar rates as high...
24/10/2024

Researchers report healthy live births after segmental aneuploid transfers, finding that they have similar rates as high level mosaic segmental aneuploids.

PGT-A can determine whether an embryo is euploid and has the right number and structure of chromosomes. In whole chromosome aneuploids, entire chromosomes are missing or duplicated, while segmental aneuploids have large pieces of chromosomes affected. These embryos are typically not transferred.

There isnโ€™t much data on the success rates of segmental aneuploids, but previous studies show that rebiopsying these embryos can lead to reclassification as a mosaic.

A new study reported pregnancy outcomes for transfers involving segmental aneuploids, finding a 24.0% live birth rate.

Although there weren't many births, all the babies were healthy, with prenatal testing showing normal results.

They also transferred high level mosaics with segmental aneuploids, finding similar live birth rates to non-mosaic segmental aneuploids.
Additionally, they also reported on a single ongoing pregnancy/live birth from a whole chromosome aneuploid transfer.

The authors conclude that segmental aneuploid results need to be differentiated from whole chromosome aneuploid results to better understand their chances of success and to help doctors and patients make informed decisions.

You can read more on Remembryo, link is in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter.

๐‡๐š๐ฏ๐ž ๐ฒ๐จ๐ฎ ๐ญ๐ซ๐š๐ง๐ฌ๐Ÿ๐ž๐ซ๐ซ๐ž๐ ๐š ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐จ๐ซ ๐ฐ๐ก๐จ๐ฅ๐ž ๐œ๐ก๐ซ๐จ๐ฆ๐จ๐ฌ๐จ๐ฆ๐ž ๐š๐ง๐ž๐ฎ๐ฉ๐ฅ๐จ๐ข๐? ๐–๐ก๐š๐ญ ๐ฐ๐ž๐ซ๐ž ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ฎ๐ฅ๐ญ๐ฌ?

A 2024 case report details a patient who had success transferring a 4 cell embryo on day 4 โ€” an embryo that some clinics...
23/10/2024

A 2024 case report details a patient who had success transferring a 4 cell embryo on day 4 โ€” an embryo that some clinics wouldnโ€™t have considered for transfer.

A 37 year old patient with diminished ovarian reserve (AMH

22/10/2024

A study published in the journal Cell reveals the proteins responsible for fertilization.

Fertilization begins with the s***m binding to the egg cell, followed by the fusion and combining of their genetic material.
It has been unclear how s***m specifically binds to the egg, but recent research provides insights.

Researchers discovered that three s***m proteinsโ€”Tmem81, Izumo1, and Spaca6โ€”work together to bind to the JUNO protein on the egg cell's surface.

This group of proteins on the s***m acts like a key, fitting into the lock of the egg cell to initiate binding.

The AI technology AlphaFold was used to predict interactions among these proteins, which led to the identification of Tmem81's role.

Animal experiments with zebrafish and mice showed that animals lacking Tmem81 were infertile, despite having normal s***m, confirming the protein's crucial role in fertility.

In the accompanying video, you can see a number of s***m (in orange) binding to the eggโ€™s zona, or shell. This binding occurs through the interaction between the s***m proteins and the JUNO protein on the egg. Once a s***m penetrates the egg, there is a massive release of calcium ions (in blue), which oscillate to activate the egg's mitochondria. This activation boosts energy production, allowing the egg to resume meiosis and complete the fertilization process.

Video used with permission, thanks to Victoria Deneke, Pauli lab, IMP Vienna.

You can read about the full study in The New York Times, link in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter.

Time for the weekly IVF research brief! Here, I take a brief look at 3 of the top new IVF studies from last week that I ...
21/10/2024

Time for the weekly IVF research brief!

Here, I take a brief look at 3 of the top new IVF studies from last week that I think are most helpful for patients.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. This study evaluated pregnancy outcomes following the transfer of non-mosaic segmental aneuploids after PGT-A, finding a 24% live birth rate. While these embryos had better outcomes than those with whole chromosome aneuploidy, their success rates were lower than for segmental mosaics.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ. Women who had a positive beta-hCG after a fresh transfer have a higher chance of success in a subsequent FET using a frozen embryo from the same cycle. There was no decrease in subsequent FET success rates if the fresh transfer didn't work.

๐’๐ญ๐ฎ๐๐ฒ ๐Ÿ‘. This case report describes a miscarriage following the transfer of a male embryo initially deemed euploid by PGT-A, with subsequent testing revealing Turner syndrome (45,X). It highlights the limitations of PGT, emphasizing the need for counseling about possible discrepancies and suggesting follow-up testing, such as short tandem repeat analysis, when discrepancies arise.

Iโ€™m short on time and canโ€™t review all these studies, so let me know which one you'd like to learn more about in detail and I can feature it next week on my IVF research news website, Remembryo. Sign up to my newsletter to make sure you donโ€™t miss it! (send me a DM with your email to be added).

More research briefs for the month and links to the studies are on Remembryo, link is in the comment.

๐–๐ก๐ข๐œ๐ก ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ฐ๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐ฅ๐ข๐ค๐ž ๐ญ๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ?

Three law firms in the US have filed a series of class action lawsuits against specific PGT companies, alleging that the...
18/10/2024

Three law firms in the US have filed a series of class action lawsuits against specific PGT companies, alleging that they misled consumers about the effectiveness of PGT-A.

On Wednesday, law firms filed class action lawsuits against PGT companies CooperGenomics, Reproductive Genetic Innovations, Progenesis and Natera, with similar suits being prepared for Ovation Fertility and Igenomix.

According to the lawsuits, PGT-A is advertised as "a proven, accurate, and reliable method to decrease the chance of miscarriage and increase the chance of giving birth to a healthy baby," despite contrary evidence.

The lawsuits provide a summary of research that shows PGT-A may be less effective and accurate than advertised, with organizations like ESHRE, the HFEA and ASRM highlighting the lack of evidence to support its routine use.

Despite these concerns, the use of PGT-A is reportedly increasing in the US, now used in nearly half of all IVF cycles and generating approximately $300-$400 million in annual revenue.

The lawsuits allege consumer fraud, breach of warranty and related claims stemming from the advertising of PGT-A. The plaintiffs seek to recover out-of-pocket expenses incurred from PGT-A testing, as well as other damages.

"We have filed these class action lawsuits to seek accountability in an industry that seems to be increasingly guided by financial gain. Members of this widening community should not be taken advantage of with misleading and deceptive assurances when they are at their most vulnerable state and are entitled to damages under consumer fraud statutes," said Allison Freeman, managing partner of Constable Law and IVF attorney.

To read the full press release and lawsuits, or to contact the lawyers, visit the link in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter.

Researchers combined the results of 38 studies investigating treatments that benefit DOR patients. DHEA, testosterone, h...
17/10/2024

Researchers combined the results of 38 studies investigating treatments that benefit DOR patients. DHEA, testosterone, high-dose gonadotropins and delayed start protocols all showed improvements.

Patients with diminished ovarian reserve (DOR) have low AMH or AFC levels and typically have a poor ovarian response during stimulation (ie. they don't produce many eggs).

Different treatment strategies have been suggested to improve outcomes for DOR patients, and a recent meta-analysis combined the results of 38 randomized controlled trials (RCTs; high quality studies) on this topic.

Letโ€™s look at the results!

Women with DOR who supplemented with DHEA before ovarian stimulation showed an increase in the number of eggs retrieved. Higher gonadotropin doses also resulted in more eggs.

Pretreatment with testosterone gel increased the number of eggs and improved pregnancy outcomes like live birth rates.

Delayed start protocols, involving an initial GnRH antagonist treatment before ovarian stimulation, increased the number of eggs and the number of mature eggs.

Letrozole and clomid didn't show any improvements for DOR patients, at least based on the RCTs included.

Additional strategies like growth hormone, luteal-phase stimulation, dual triggering, dual stimulation, the use of LH, estradiol pretreatment and the use of corifollitropin alfa were also explored, with mixed results. There were fewer RCTs addressing these treatments in the meta-analysis.

๐ƒ๐จ ๐ฒ๐จ๐ฎ ๐ก๐š๐ฏ๐ž ๐ƒ๐Ž๐‘? ๐–๐ก๐š๐ญ ๐ก๐š๐ฌ ๐ฐ๐จ๐ซ๐ค๐ž๐ ๐Ÿ๐จ๐ซ ๐ฒ๐จ๐ฎ ๐ญ๐จ ๐›๐จ๐จ๐ฌ๐ญ ๐ž๐ ๐  ๐ง๐ฎ๐ฆ๐›๐ž๐ซ๐ฌ ๐š๐ง๐ ๐จ๐ญ๐ก๐ž๐ซ ๐จ๐ฎ๐ญ๐œ๐จ๐ฆ๐ž๐ฌ?

Check out all the details on Remembryo, link is in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter.

PGT-A tested euploid embryos don't always work!PGT-A is a technique used to select "euploid" embryos that have the right...
16/10/2024

PGT-A tested euploid embryos don't always work!

PGT-A is a technique used to select "euploid" embryos that have the right number/structure of chromosomes.

These euploids are *not* a guaranteed thing. Let's look at some of the reasons why:

1) Besides the embryo, the uterine environment is also important for implantation. Some patients might have endometritis or endometriosis that could disrupt implantation.

2) PGT-A can't detect small changes in DNA. Some embryos might have genetic mutations that affect their normal development that are too tiny to be detected by PGT-A.

3) A 5-10 cell biopsy might not be representative of the whole embryo, which could be hundreds of cells. It's possible that the "euploid" transferred is actually a mosaic that didn't self-correct.

4) Embryo quality, and the day the embryo was biopsied, still matter. Good quality euploids have a better chance than poor quality euploids; day 5 euploids have a better chance than day 7.

5) The proficiency of the embryology team and the doctor that performs the transfer also matters.

Still, studies have shown that euploid transfers can be very successful. In one study, a single euploid transfer had about a 65% chance of live birth, but after 3 consecutive transfers the overall (cumulative) chance was about 93%.

๐‡๐š๐ฏ๐ž ๐ฒ๐จ๐ฎ ๐ก๐š๐ ๐š ๐Ÿ๐š๐ข๐ฅ๐ž๐ ๐ž๐ฎ๐ฉ๐ฅ๐จ๐ข๐ ๐ญ๐ซ๐š๐ง๐ฌ๐Ÿ๐ž๐ซ? ๐€๐ง๐ฒ ๐ข๐๐ž๐š ๐จ๐ง ๐ฐ๐ก๐š๐ญ ๐ฐ๐ž๐ง๐ญ ๐ฐ๐ซ๐จ๐ง๐ ?

Read more about PGT-A on Remembryo, link is in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter.

A 2024 randomized controlled trial found that Zymot-selected s***m didnโ€™t improve embryo euploidy rates, but increased f...
15/10/2024

A 2024 randomized controlled trial found that Zymot-selected s***m didnโ€™t improve embryo euploidy rates, but increased fertilization rates.

During IVF, semen is processed to concentrate the motile s***m. This is often done using density gradient centrifugation, but other methods can be used like microfluidics (ie. Zymot).

These devices have been shown to select s***m with lower s***m DNA fragmentation (SDF), and itโ€™s possible that this could improve euploidy rates.

A new study compared euploidy rates for embryos that were created from s***m processed using Zymot or density gradient centrifugation.

They found that there was no improvement in euploidy rate or blastocyst formation rates, but fertilization rates increased.

Other studies on the subject have been mixed, with some showing improvements in euploidy rates and other outcomes.

Itโ€™s important to point out that this study was done in the general IVF population, and not in patients with high SDF, who might show improved euploidy rates.

Regardless, the authors note that using microfluidics for s***m processing is easier and faster than density gradient centrifugation, with likely improvements in fertilization and reduced SDF levels.

๐‡๐š๐ฏ๐ž ๐ฒ๐จ๐ฎ ๐จ๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ ๐›๐ž๐ž๐ง ๐ž๐ฏ๐š๐ฅ๐ฎ๐š๐ญ๐ž๐ ๐Ÿ๐จ๐ซ ๐’๐ƒ๐…? ๐‡๐š๐ฏ๐ž ๐ฒ๐จ๐ฎ ๐ญ๐ซ๐ข๐ž๐ ๐™๐ฒ๐ฆ๐จ๐ญ ๐จ๐ซ ๐š๐ง๐จ๐ญ๐ก๐ž๐ซ ๐ฆ๐ข๐œ๐ซ๐จ๐Ÿ๐ฅ๐ฎ๐ข๐๐ข๐œ๐ฌ ๐๐ž๐ฏ๐ข๐œ๐ž ๐Ÿ๐จ๐ซ ๐ฌ๐ฉ๐ž๐ซ๐ฆ ๐ฉ๐ซ๐จ๐œ๐ž๐ฌ๐ฌ๐ข๐ง๐ ?

Check out all the details on Remembryo, link is in the comments. Want to stay up to date on new IVF research and news? Send me a DM with your email and I'll sign you up to my weekly newsletter.

Address


Alerts

Be the first to know and let us send you an email when Embryoman posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Embryoman:

Videos

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Videos
  • Claim ownership or report listing
  • Want your business to be the top-listed Media Company?

Share

I am Embryoman-your friendly neighborhood embryologist!

Remembryo is my blog for evidence based IVF information (www.remembryo.com). Hereโ€™s what I got so far:


  • Embryo grading and success rates (https://www.remembryo.com/embryo-grading/)

  • PGS testing (https://www.remembryo.com/pgs-testing/)

  • Mosaic embryos (https://www.remembryo.com/mosaic-embryo/)